Matches 201 - 250 out of 291 < 1 2 3 4 5 6 >
Match Document Document Title
5015480 Film coating formulations  
Aqueous diffusion coating formulations suitable for use on pharmaceutical dosage forms comprising an admixture of an insoluble polymer component of a copolymer of ethylacrylate and...
5013728 Composition for treating osteoporosis and hormonal imbalance  
A medication for providing fluoride ion for the prevention and treatment of bone loss disease, together with an estrogen-containing substance for not only treating hormonal imbalance but to obtain...
5002776 Controlled absorption diltiazem formulations  
A controlled absorption diltiazem pellet formulation for oral administration comprises a core of diltiazem or a pharmaceutically acceptable salt thereof in association with an organic acid, and a...
4990341 Controlled release hydromorphone composition  
A solid controlled release, oral dosage form, the dosage form comprising a therapeutically effective amount of hydromorphone or a salt thereof in a matrix wherein the dissolution rate in vitro of...
4968505 Long-acting diclofenac sodium preparation  
A long-acting diclofenac sodium preparation is disclosed. The preparation comprises a sustained-release diclofenac sodium component which is prepared by coating a sustained-release coat onto a...
4966770 Prednisone microencapsulated granules  
The invention disclosed is prednisone microencapsulated granules with activity densities greater than about 0.030 g/ml. These granules are unusually small, having diameters less than about 1000...
4965072 Granulating composition and method  
The invention involves a granulating composition composed of an aqueous solution of magnesium sulfate heptahydrate and sodium hexametaphosphate. This composition can be used to prepare granules of...
4963365 Controlled release dosage form  
A controlled release dosage form which consists essentially of a core containing a medicament; an inner coating layer composed of ethylcellulose and a hydrophobic substance; and an outer coating...
4959220 Antiseptic-containing alginate impression material  
An antiseptic-containing alginate impression material contains 0.01 to 7 parts by weight of an antiseptic such as glutaraldehyde and chlorohexydine gluconate per 100 parts by weight of a cured...
4959219 Coating barriers comprising ethyl cellulose  
Coatings for individual ion exchange resin particles comprised of (a) ethylcellulose and (b) corn oil or acetylated monoglycerides.
4957745 Pharmaceutical preparation  
Controlled release preparation containing a number of beads comprising a salt of metoprolo as the main soluble component, a method for the production thereof and the use in the treatment of...
4940587 Oral pharmaceutical composition through mucosa  
An arrangement is provided for the application of an oral pharmaceutical to the mucosa of the oral or nasal cavity, for sustained release there of the drug. The arrangement of the invention...
4938968 Controlled release indomethacin  
In accordance with the present invention, the controlled release formulation contains coated pellets of indomethacin of only one type. The pellet releases indomethacin in both immediate and...
4927640 Controlled release beads having glass or silicon dioxide core  
Controlled release preparation containing a number of insoluble beads applied with one or more pharmaceutically active compounds, a method for the production thereof and the use in a treatment...
4919938 Sustained release pharmaceutical compositions in oral dosage form  
Oral dosage forms for neutral, zwitterions or slats of acidic or basic drugs with approximate zero order release kinetics comprise a core matrix of the drug, and a gelling polymer, the matrix being...
4917899 Controlled absorption diltiazem formulation  
A diltiazem pellet formulation for oral administration comprises a core of diltiazem or a pharmaceutically acceptable salt thereof in association with an organic acid and a lubricant, and a...
4917900 Controlled release formulations containing zidovudine  
The invention relates to pharmaceutical formulations comprising discrete units of zidovudine provided with a controlled release coating in which the said units are preferably in the form of spheroids.
4894239 Sustained-release preparation and production thereof  
The present invention concerns a sustained-release microcapsule preparation comprising an ion exchange resin with 6 to 16% crosslinking, containing a drug adsorbed in an amount not less than 80% of...
4891230 Diltiazem formulation  
A diltiazem pellet formulation for oral administration comprises a core of diltiazem or a pharmaceutically acceptable salt thereof in association with an organic acid, and a multi-layer membrane...
4888177 Pharamaceutical preparations in the form of instant granules or tablets and process for their manufacture  
The invention relates to a pharmaceutical preparation that contains at least one pharmaceutically active substance at least one granular carrier material and a layer enveloping the carrier material...
4882169 Swellable pellets  
Pellets which can be used in liquid oral formulations of drugs are presented. They comprise (a) a core, containing microparticles of at least one pharmaceutically active substance, (b) optionally...
4871549 Time-controlled explosion systems and processes for preparing the same  
The invention relates to a Time-Controlled Explosion System in which drug release is caused by explosion of a membrane after a definite time period, said System comprising a preparation in the form...
4865851 Pharmaceutical composition comprising cefuroxime axetil  
Cefuroxime axetil in particulate form is coated with an integral coating of a lipid or mixture of lipids which serves to mask the bitter taste of cefuroxime axetil but disperses or dissolves on...
4863743 Controlled release potassium chloride  
A controlled release potassium chloride tablet is disclosed which is comprised of potassium chloride crystals having a mesh size of about 30 to about 50 mesh which are coated with a coating...
4861599 Galenic formulations for oral use of rhein derivatives with delayed release for therapeutical use  
Several methods are disclosed for the preparation of oral pharmaceutical forms with delayed release of rhein and its derivatives. The pharmaceutically active ingredient is provided in the form of...
4859469 Novel galenic forms of verapamil, their preparation and medicines containing said novel galenic forms  
The invention relates to a novel galenic form of verapamil which show an excellent bioavailability. The novel galenic form comprises microgranules containing a verapamil addition salt with an acid,...
4847077 Controlled release pharmaceutical preparations  
Controlled release pharmaceutical preparations containing coated sulfonic acid cationic exchange resin drug complex particles, the resin particles having been treated, prior to coating, with about...
4844910 Spheroids  
A controlled release pharmaceutical composition comprising a plurality of film coated spheroids, the film coated spheroids comprising a 3-alkylxanthine, a non-water soluble spheronising agent and...
4840799 Process for preparing rapidly disintegrating granulates  
The present invention relates to a process for preparing a rapidly disintegrating core granulate containing a pharmaceutically active compound, which granulate is optionally intended to be coated...
4832955 Controlled release potassium chloride composition  
The invention is directed to a pharmaceutical composition comprising a microencapsulated potassium salt encapsulated in a shell wall consisting essentially of from about 85% to about 97% ethyl...
4830859 Process for lubricating water-soluble vitamin powders  
The subject invention relates to a process for preparing lubricated water-soluble vitamin powders. The water-soluble vitamin powders are lubricated by combining them with a lubricant at a...
4816264 Sustained release formulations  
Drug delivery systems which exhibit sustained release properties when administered are produced using a "dual control" system which employs polymeric agents in core and membrane portions.
4808411 Antibiotic-polymer compositions  
Compositions which comprise a complex of carbomer (acrylic acid polymers) and erythromycin or a derivative thereof such as 6-O-methylerythromycin, are disclosed. The compositions provide nontoxic,...
4806361 Medicaments in sustained release unit dose form  
Sustained-release compositions for oral administration comprising medicament-coated nonpareils surrounded by a sustaining coating of at least three admixed polymers afford exceptionally good plasma...
4800084 Pharmaceutical product in the form of a pellet with continuous, delayed medicament substance emission  
The discovery presented herewith concerns a pharmaceutical product in the form of a pellet with improved continous, delayed medicament substance emission through a coating, which is made of a...
4771077 Spray dried acetaminophen  
A therapeutic taste-neutral powder form of acetaminophen obtained by spray-drying a suspension of colloidal silica in a lower alkanol solution of acetaminophen and ethyl cellulose.
4754027 Process for preparing a product comprising guar-gum  
The present invention relates to a process for preparing a product comprising guar-gum present in the form of particles, and possessing a sustained swelling in an aqueous suspension, whereby...
4748023 Process for the preparation of sustained release pharmaceutical compositions having a high active ingredient content  
The invention relates to a process for the preparation of sustained release solid pharmaceutical compositions having an active ingredient content of at least 80% and possessing a structure which...
4729895 Composition for solid pharmaceutical preparations of active vitamins D.sub. 3  
This invention is concerned with a composition for solid pharmaceutical preparations of active vitamins D 3 , having the remarkably improved stability of active vitamins D 3 , and an extremely...
4728513 Granular delayed-release form of pharmaceutically active substances  
A granular delayed-release form of pharmaceutically active substances, which is prepared by coating a granulated or crystalline pharmaceutically active substance, or mixtures thereof, with a...
4675175 Coated methionine granules for ruminants  
Composition for coating a biologically active substance, which is stable in a medium of which the pH is greater than or equal to 5, and which permits the release of the active substance in a medium...
4656027 Pharmaceutical mixture  
The present invention is concerned with masking bad taste in pharmaceutical preparations containing encapsulated drugs with bad taste. The object of the invention is achieved by including a basic...
4652442 Process of producing a sustained release preparation containing indomethacin or niomethacin  
In a process of producing a sustained release preparation containing indomethacin or niomethacin, the active ingredient in the form of a powder as well as one or more food grade substances having a...
4634587 Sustained release quinidine dosage form  
A sustained release quindine dosage form is made from a plurality of pellets. Each pellet includes a quinidine-containing coating over a nonpareil seed, with a further coating of about 5 to about...
4606940 Small particle formation and encapsulation  
Process for the formation and the simultaneous encapsulation of small particles of a compound from solution which comprises: (a) dissolving said compound in a first solvent; (b) preparing a...
4540602 Process for the preparation of activated pharmaceutical compositions  
Disclosed is a process for the preparation of an activated pharmaceutical composition containing a solid drug that is scarcely soluble in water, the pharmaceutical composition being characterized...
4508702 Sustained release aspirin  
A sustained release aspirin dosage form permits the continuous delivery of aspirin into the gastrointestinal tract for a period of at least eight hours. The sustained release aspirin dosage form...
4490407 Method for preparing galenic formulations particularly for pharmaceutical, dietetical, cosmetic and diagnostic uses  
A method for preparing a galenic formulation for pharmaceutical, dietetic, cosmetic or diagnostic use, comprising forming a liquid mixture containing at least one active ingredient and at least one...
4486471 Process for preparing ethylcellulose microcapsules  
Pharmaceutically active compound-containing microcapsules the coating walls of which consist essentially of ethylcellulose and a water-insoluble, acid-soluble polymer material are disclosed. A...
4462982 Microcapsules and method of preparing same  
Ethylcellulose microcapsules, wherein a polymer material which shows at least 1.2 times increase in weight by immersing it in water at 37° C. is incorporated into the ethylcellulose coating walls...
Matches 201 - 250 out of 291 < 1 2 3 4 5 6 >